An alginate hydrogel delivering human β-defensin 2 significantly accelerated diabetic wound healing in mice by reducing bacteria, inflammation, and oxidative stress while promoting new blood vessel and tissue growth.
Multi-action wound healinghBD-2 hydrogel simultaneously reduced bacteria, shifted immune cells to healing mode, lowered oxidative stress, and increased blood vessel and collagen formation in diabetic wounds
What the researchers found
Alginate-based hydrogels provided sustained hBD-2 release for over 3 days with stable properties across pH 6-8. In vitro, hBD-2 hydrogels showed excellent biocompatibility and superior cell migration promotion compared to PP4-3.1 hydrogels. In a diabetic mouse wound model, hBD-2 hydrogels significantly: accelerated wound closure, improved re-epithelialization and tissue remodeling, reduced microbial wound load, decreased M1-like macrophages and M1/M2 ratio (shifting toward anti-inflammatory phenotype), reduced CD3+ cells, lowered reactive oxygen species levels, and increased neovascularization and collagen deposition.
Why it matters
Diabetic foot ulcers affect approximately 25% of diabetes patients and cause over 100,000 amputations annually in the US alone. Current treatments fail to address all the factors that impair healing. This hBD-2 hydrogel simultaneously fights infection, calms inflammation, reduces oxidative damage, and promotes tissue repair — a multi-pronged approach matching the complexity of diabetic wound pathology.
How the study worked
Alginate hydrogels were designed to deliver two AMPs (hBD-2 and PP4-3.1). Physical characterization included rheology, swelling, porosity, and release kinetics. In vitro testing assessed biocompatibility and cell migration. hBD-2 hydrogels were tested in a streptozotocin-induced diabetic mouse wound model, with outcomes including wound closure rate, histological maturation, microbial load, inflammatory markers (macrophage phenotype, CD3+ cells), ROS levels, neovascularization, and collagen deposition.
What this study cannot tell us
This is a preclinical study using a mouse diabetic wound model. Mouse wound healing differs from human (contraction vs granulation). The streptozotocin model mimics type 1 diabetes more than type 2, which causes most diabetic foot ulcers. Specific wound closure rates and statistical comparisons were not detailed in the abstract. Long-term outcomes and comparison to existing clinical wound treatments were not assessed.
How to read the evidence
This is a preclinical study with thorough in vitro characterization and in vivo diabetic mouse wound model validation. The comprehensive analysis of multiple healing parameters is a strength, but mouse-to-human translation remains uncertain.
When this study was published
Published in 2025, this study represents the cutting edge of antimicrobial peptide-biomaterial combination therapies for chronic wound management.
The bigger picture
The convergence of antimicrobial peptides and advanced hydrogel biomaterials represents a new generation of wound care. Unlike traditional antibiotics, defensin peptides have immunomodulatory properties that go beyond killing bacteria. This study demonstrates that harnessing these dual functions in a sustained-release system can address the root causes of impaired diabetic wound healing — a concept applicable to other chronic wound types.
Questions still open
- How do hBD-2 hydrogels compare to current standard-of-care diabetic wound treatments like negative pressure therapy or growth factor applications?
- Would this approach work in human diabetic foot ulcers where wound chronicity and biofilm formation are major challenges?
- Can the hydrogel formulation be optimized for longer release periods to reduce dressing change frequency?
Common questions
What makes diabetic wounds so hard to heal?
What is human β-defensin 2 and why use it in a wound dressing?
Read the original research
Alginate-based hydrogels for sustained antimicrobial peptide delivery to enhance wound healing in diabetes.
Biomaterials advances, 175, 214337
Citation
Da Silva, Jessica; Leal, Ermelindo C; Gomes, Ana; Gomes, Paula; Calheiros, Daniela; Gonçalves, Teresa; Carvalho, Eugénia; Silva, Eduardo A. (2025). Alginate-based hydrogels for sustained antimicrobial peptide delivery to enhance wound healing in diabetes.. Biomaterials advances, 175, 214337. https://doi.org/10.1016/j.bioadv.2025.214337